Difficulty: Medium
Average Score: 62%
Practice
Streptokinase:
Correct answer
A
Rationale
Rationale:
The correct answer is A) Is derived from streptococci.
Streptokinase is indeed derived from streptococci bacteria. It is an enzyme that acts as a thrombolytic agent by converting plasminogen to plasmin, which helps dissolve blood clots. This action is beneficial in conditions like acute myocardial infarction where prompt restoration of blood flow to the heart muscle is crucial.
B) Reducing acute mortality of myocardial infarction within 4 hours is incorrect because streptokinase has shown benefit even when administered beyond this timeframe. The key factor is early administration, but the 4-hour limit is not a strict rule.
C) Contraindication with regular NSAID therapy is incorrect. While caution is advised due to potential bleeding risks, it is not an absolute contraindication. The decision should be based on the individual patient's risk-benefit profile.
D) Restricting streptokinase based on age over 60 is incorrect. Age alone is not a contraindication. The decision to use streptokinase should be guided by overall clinical assessment and not solely by age.
Educational Context:
Understanding the properties and appropriate use of cardiovascular drugs, including thrombolytics like streptokinase, is crucial for healthcare professionals. Knowing the mechanism of action, indications, contraindications, and potential adverse effects helps in making informed decisions for patient care. It is also important to stay updated with current guidelines and research findings to provide optimal treatment outcomes for patients with cardiovascular conditions.
The correct answer is A) Is derived from streptococci.
Streptokinase is indeed derived from streptococci bacteria. It is an enzyme that acts as a thrombolytic agent by converting plasminogen to plasmin, which helps dissolve blood clots. This action is beneficial in conditions like acute myocardial infarction where prompt restoration of blood flow to the heart muscle is crucial.
B) Reducing acute mortality of myocardial infarction within 4 hours is incorrect because streptokinase has shown benefit even when administered beyond this timeframe. The key factor is early administration, but the 4-hour limit is not a strict rule.
C) Contraindication with regular NSAID therapy is incorrect. While caution is advised due to potential bleeding risks, it is not an absolute contraindication. The decision should be based on the individual patient's risk-benefit profile.
D) Restricting streptokinase based on age over 60 is incorrect. Age alone is not a contraindication. The decision to use streptokinase should be guided by overall clinical assessment and not solely by age.
Educational Context:
Understanding the properties and appropriate use of cardiovascular drugs, including thrombolytics like streptokinase, is crucial for healthcare professionals. Knowing the mechanism of action, indications, contraindications, and potential adverse effects helps in making informed decisions for patient care. It is also important to stay updated with current guidelines and research findings to provide optimal treatment outcomes for patients with cardiovascular conditions.